Literature DB >> 24635080

New intragenic and promoter region deletion mutations in FERMT1 underscore genetic homogeneity in Kindler syndrome.

D Fuchs-Telem1, J Nousbeck, A Singer, J A McGrath, O Sarig, E Sprecher.   

Abstract

BACKGROUND: Kindler syndrome (KS) is a rare autosomal recessive skin disorder, which was recently reclassified as a subtype of epidermolysis bullosa. Despite the fact that loss-of-function mutations in the FERMT1 gene, encoding kindlin-1, have been shown to cause the syndrome in numerous patients, a small number of typical cases of KS in which FERMT1 mutations could not be identified has raised the possibility that the disorder may be genetically heterogeneous. AIM: To assess two highly consanguineous families with clinical characteristics of KS.
RESULTS: In the first family, a hitherto unreported deletion (c.137-140delTAGT) in FERMT1 was detected, which is predicted to lead to premature termination of translation. However, direct sequencing of the coding region of FERMT1 failed to disclose any pathogenic change in the second family. To confirm the possibility that the disease in this family may be due to a mutation in another gene, we used homozygosity mapping, and found that all affected family members share a segment of homozygosity on 20p12.3, spanning the FERMT1 gene. Accordingly, a large and highly unusual deletion (g.-711-1241del) spanning the putative FERMT1 promoter sequence and the first noncoding exon of the gene was found to cosegregate with the disease phenotype in this family, and to prevent transcription of the gene, as attested by the lack of FERMT1 message in the skin of a patient.
CONCLUSION: The present data provide evidence in support of genetic homogeneity in KS.
© 2014 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24635080     DOI: 10.1111/ced.12222

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  6 in total

1.  A Deep-Intronic FERMT1 Mutation Causes Kindler Syndrome: An Explanation for Genetically Unsolved Cases.

Authors:  Nadja Chmel; Sorina Danescu; Amelie Gruler; Dimitra Kiritsi; Leena Bruckner-Tuderman; Alexander Kreuter; Jürgen Kohlhase; Cristina Has
Journal:  J Invest Dermatol       Date:  2015-06-17       Impact factor: 8.551

2.  The Kindler syndrome: a spectrum of FERMT1 mutations in Iranian families.

Authors:  Leila Youssefian; Hassan Vahidnezhad; Mohammadreza Barzegar; Qiaoli Li; Soheila Sotoudeh; Ameneh Yazdanfar; Amir Hooshang Ehsani; Abdol-Mohammad Kajbafzadeh; Nikoo Mozafari; Nasser Ebrahimi Daryani; Farzaneh Agha-Hosseini; Sirous Zeinali; Jouni Uitto
Journal:  J Invest Dermatol       Date:  2015-01-19       Impact factor: 8.551

3.  KIND1 Loss Sensitizes Keratinocytes to UV-Induced Inflammatory Response and DNA Damage.

Authors:  Xiaoling Zhang; Suju Luo; Joseph Wu; Long Zhang; Wen-Hui Wang; Simone Degan; Detlev Erdmann; Russell Hall; Jennifer Y Zhang
Journal:  J Invest Dermatol       Date:  2016-10-07       Impact factor: 8.551

4.  Assessment of the risk and characterization of non-melanoma skin cancer in Kindler syndrome: study of a series of 91 patients.

Authors:  Sara Guerrero-Aspizua; Claudio J Conti; Maria Jose Escamez; Daniele Castiglia; Giovanna Zambruno; Leila Youssefian; Hassan Vahidnezhad; Luis Requena; Peter Itin; Gianluca Tadini; Ivelina Yordanova; Ludovic Martin; Jouni Uitto; Cristina Has; Marcela Del Rio
Journal:  Orphanet J Rare Dis       Date:  2019-07-24       Impact factor: 4.123

5.  Clinical practice guidelines for laboratory diagnosis of epidermolysis bullosa.

Authors:  C Has; L Liu; M C Bolling; A V Charlesworth; M El Hachem; M J Escámez; I Fuentes; S Büchel; R Hiremagalore; G Pohla-Gubo; P C van den Akker; K Wertheim-Tysarowska; G Zambruno
Journal:  Br J Dermatol       Date:  2019-08-09       Impact factor: 9.302

Review 6.  Novel Discoveries in Immune Dysregulation in Inborn Errors of Immunity.

Authors:  Anwen Ren; Wei Yin; Heather Miller; Lisa S Westerberg; Fabio Candotti; Chan-Sik Park; Pamela Lee; Quan Gong; Yan Chen; Chaohong Liu
Journal:  Front Immunol       Date:  2021-08-27       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.